Pharmaceutical Administration Bureau has approved IASO Biotherapeutics’ new drug application (NDA) for equecabtagene ...

Yesterday afternoon, Professor of Art History Pamela Fletcher was joined in celebration of her newly published book “The Victorian Painting of Modern Life.” ...

A clinical team has spearheaded the use of CAR-T cell therapy for blood cancers. The researchers recently treated the first ...

徐州医科大学肿瘤生物治疗研究所郑骏年、施明研究团队联合徐州医科大学附属医院崔桂云研究团队在hLife上发表了题为“BCMA-CD19 bispecific CAR-T therapy in refractory chronic ...

3月12日，强生/传奇生物宣布，将投资1.5亿美元扩建其位于比利时的细胞治疗生产设施，以提升CAR-T疗法的产能。该工厂目前负责生产强生/传奇生物的旗舰产品Carvykti（西达基奥仑赛），用于治疗多发性骨髓瘤。 预计到2025年底前，该工厂将获得商业供应批准，新投资将主要用于扩大欧盟市场供应。 与此同时，传奇生物发布了2024财年业绩。全年营收达6.21亿美元（+118%），净亏损1.77亿美元 ...

The global CAR T-cell therapy market is projected to grow from USD 2.7 billion in 2025 to over USD 27.5 billion by 2033, ...

The research team, led by Professors Kwong Yok-lam (front right) and Eric Tse Wai-choi (front left), successfully utilises ...

Reports Q4 revenue $2.9M, consensus $13.03M. “2024 was a pivotal year for 2seventy as we made significant changes to our business to streamline ...

The Bombay High Court, hearing a plea against notices issued by civic bodies to bakeries to convert to green fuel, asked the ...

Following this, the BMC and the Public Health Department issued notices to bakeries, hotels, and other commercial ...